February 2021 Archives by thread
Starting: Mon Feb 1 09:22:46 PST 2021
Ending: Wed Feb 24 22:35:04 PST 2021
Messages: 45
- [Ip-health] NEW South Centre Policy Brief: WIPO Negotiations for an International Legal Instrument on Intellectual Property and Genetic Resources
Anna Bernardo
- [Ip-health] Bloomberg: Von Der Leyen Blames EU Trade Chief for Vaccine Export Gaffe
Thiru Balasubramaniam
- [Ip-health] Op-ed by Dr. TEDROS ADHANOM GHEBREYESUS in Foreign Policy - Vaccine Nationalism Harms Everyone and Protects No One
Thiru Balasubramaniam
- [Ip-health] Statement: COVAX’s vaccine supply is terrifyingly inadequate
Peter Maybarduk
- [Ip-health] Korean CSOs called on SKG to support TRIPS waiver proposal
Heesob Nam
- [Ip-health] KEI Roundtable on Pathways to Scale Up Manufacturing Capacity for COVID-19 Vaccines – 19 February 2021
Thiru Balasubramaniam
- [Ip-health] COVID-19 Contract Repository
Claire Cassedy
- [Ip-health] As COVAX Falls Short, Biden Administration Continues to Block Efforts to Scale-up Global COVID-19 Vaccine Supply
Baker, Brook
- [Ip-health] MSF to wealthy countries: Don’t block and ruin the potential of a landmark waiver on monopolies during the pandemic
Yuanqiong HU
- [Ip-health] The OWS Novavax fair and reasonable price provision in the $1.6 billion vaccine contract
James Love
- [Ip-health] 100 CSO Call on WTO Members To Support LDCs Request for Extension of Transition Period
Sangeeta Shashikant
- [Ip-health] Cracks in the opposition to the TRIPS Waiver?
Priti Patnaik
- [Ip-health] WHO Director-General's opening remarks at the media briefing on COVID-19 – 5 February 2021
Thiru Balasubramaniam
- [Ip-health] NYT Opinion: It’s Time to Trust China’s and Russia’s Vaccines
K.M. Gopakumar
- [Ip-health] TWN Info: Developing countries call for text-based negotiations on TRIPS waiver
Chee Yoke Ling
- [Ip-health] Fwd: TWN Info: WTO dithers on TRIPS waiver, COVID-19 vaccine access gap grows
Chee Yoke Ling
- [Ip-health] Feb 25, Webinar - The implementation of the TRIPS Agreement by Least Developed Countries: preserving policy space for innovation and access to medicines
Marcela Vieira
- [Ip-health] KEI's comments on the Biden administration's first Special 301 list
James Love
- [Ip-health] The Path to Racial Justice Runs Through This Agency
Tahir Amin
- [Ip-health] The Intercept: South African Archbishop denounces coronavirus vaccine apartheid
Thiru Balasubramaniam
- [Ip-health] Open Lectures on Intellectual Property for Commoning Medical Technologies and Tackling Present and Future Pandemic Outbreaks
Heesob Nam
- [Ip-health] U.S. groups, please sign-on to Biden: End US Opposition to TRIPS Waiver
Peter Maybarduk
- [Ip-health] New South Centre Paper: Intellectual Property in the EU–MERCOSUR FTA: A Brief Review of the Negotiating Outcomes of a Long-Awaited Agreement
Anna Bernardo
- [Ip-health] New Episode of Talk is the Best Medicine Podcast on February 23rd with Dr. Robert Steinglas
Global Health Impact Project
- [Ip-health] Brussels will also foster “the creation of a collaborative licensing tool, which would allow technology owners to retain a continued control over their rights while guaranteeing that technology, know-how and data are effectively shared with a wider group of manufacturers,” the draft proposals say.
James Love
- [Ip-health] Highlights from the EU's new HERA Incubator: Anticipating together the threat of COVID-19 variants
James Love
- [Ip-health] New Episode of Talk is the Best Medicine Podcast on February 25th with Dr. Gopal Sreenivasan
Global Health Impact Project
- [Ip-health] Analysis: How a $25 billion USG investment can help vaccinate the world
Peter Maybarduk
- [Ip-health] EIFL calls on WTO to support LDCs TRIPS transition request
Sangeeta Shashikant
- [Ip-health] South Africa leads backlash against big pharma over access to Covid vaccines
Sangeeta Shashikant
- [Ip-health] What's holding back the C-TAP? [Geneva Health Files]
Priti Patnaik
- [Ip-health] Popular Science: We’ve barely made a dent in vaccinating the world against COVID-19 - Getting the vaccine to every country won’t be easy, but it can be done.
Thiru Balasubramaniam
- [Ip-health] The Economist: The WTO has a new chief. Is it time for new trade rules too?
Thiru Balasubramaniam
- [Ip-health] Incoming WTO Director-General calls for ‘third way’ towards scaling up manufacturing of COVID-19 vaccines
Thiru Balasubramaniam
- [Ip-health] Washington Post: Moderna agreed to ‘equitable access’ for its coronavirus vaccine, but most of its doses are going to wealthy countries
Thiru Balasubramaniam
- [Ip-health] Scope of Compulsory License and Government Use of Patented Medicines in the Context of the COVID-19 Pandemic
Anna Bernardo
- [Ip-health] Manufacturers of COVID-19 vaccines typically start delivering in under six months after tech transfer
Luis Gil Abinader
- [Ip-health] Invitation to register for UNCTAD/WHO event on Pandemic preparedness beyond COVID-19: Investing in vaccines production and supply for LMICs. 3 March 14:00-16:00 CET
Christoph Spennemann
- [Ip-health] New Resource on Covid-19 Vaccine Access
Marcela Vieira
- [Ip-health] SouthViews: Access to Medical Equipment in a Pandemic Situation: Importance of Localized Supply Chains and 3D Printing
Anna Bernardo
- [Ip-health] TRIPS Waiver: Holy See Statement
Sangeeta Shashikant
- [Ip-health] Reminder - Feb 25, Webinar - The implementation of the TRIPS Agreement by Least Developed Countries: preserving policy space for innovation and access to medicines
Marcela Vieira
- [Ip-health] Health GAP: Press Release - Biden’s USTR Must Stop Obstructing Global Access to COVID-19 Vaccines by Supporting the TRIPS Waiver Proposal Led by South Africa and India
Baker, Brook
- [Ip-health] KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) roadmap
Thiru Balasubramaniam
Last message date:
Wed Feb 24 22:35:04 PST 2021
Archived on: Wed Feb 24 22:37:00 PST 2021
This archive was generated by
Pipermail 0.09 (Mailman edition).